282 related articles for article (PubMed ID: 17255143)
21. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
22. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
[TBL] [Abstract][Full Text] [Related]
23. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of silver-impregnated central venous catheters for preventing catheter-related blood stream infections: a meta-analysis.
Chen YM; Dai AP; Shi Y; Liu ZJ; Gong MF; Yin XB
Int J Infect Dis; 2014 Dec; 29():279-86. PubMed ID: 25447733
[TBL] [Abstract][Full Text] [Related]
25. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
Yücel N; Lefering R; Maegele M; Max M; Rossaint R; Koch A; Schwarz R; Korenkov M; Beuth J; Bach A; Schierholz J; Pulverer G; Neugebauer EA
J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696
[TBL] [Abstract][Full Text] [Related]
26. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
[TBL] [Abstract][Full Text] [Related]
27. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
[TBL] [Abstract][Full Text] [Related]
28. Recommendations and reports about central venous catheter-related infection.
Bacuzzi A; Cecchin A; Del Bosco A; Cantone G; Cuffari S
Surg Infect (Larchmt); 2006; 7 Suppl 2():S65-7. PubMed ID: 16895510
[TBL] [Abstract][Full Text] [Related]
29. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.
Raad I; Mohamed JA; Reitzel RA; Jiang Y; Raad S; Al Shuaibi M; Chaftari AM; Hachem RY
Antimicrob Agents Chemother; 2012 Feb; 56(2):935-41. PubMed ID: 22123686
[TBL] [Abstract][Full Text] [Related]
30. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.
Antonelli M; De Pascale G; Ranieri VM; Pelaia P; Tufano R; Piazza O; Zangrillo A; Ferrario A; De Gaetano A; Guaglianone E; Donelli G
J Hosp Infect; 2012 Oct; 82(2):101-7. PubMed ID: 22938728
[TBL] [Abstract][Full Text] [Related]
31. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
Templeton A; Schlegel M; Fleisch F; Rettenmund G; Schöbi B; Henz S; Eich G
Infection; 2008 Aug; 36(4):322-7. PubMed ID: 18663408
[TBL] [Abstract][Full Text] [Related]
32. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.
Hanna H; Bahna P; Reitzel R; Dvorak T; Chaiban G; Hachem R; Raad I
Antimicrob Agents Chemother; 2006 Oct; 50(10):3283-8. PubMed ID: 17005806
[TBL] [Abstract][Full Text] [Related]
34. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
35. Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis.
Dezfulian C; Lavelle J; Nallamothu BK; Kaufman SR; Saint S
Crit Care Med; 2003 Sep; 31(9):2385-90. PubMed ID: 14501971
[TBL] [Abstract][Full Text] [Related]
36. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria.
Yorganci K; Krepel C; Weigelt JA; Edmiston CE
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):379-84. PubMed ID: 12072923
[TBL] [Abstract][Full Text] [Related]
38. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.
Ramritu P; Halton K; Collignon P; Cook D; Fraenkel D; Battistutta D; Whitby M; Graves N
Am J Infect Control; 2008 Mar; 36(2):104-17. PubMed ID: 18313512
[TBL] [Abstract][Full Text] [Related]
39. Each lumen is a potential source of central venous catheter-related bloodstream infection.
Dobbins BM; Catton JA; Kite P; McMahon MJ; Wilcox MH
Crit Care Med; 2003 Jun; 31(6):1688-90. PubMed ID: 12794405
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
